Cancer drugs have become increasingly expensive in recent years. No one blinks anymore when a new lung cancer or colon cancer treatment comes to market priced at more than $100,000 per patient. In part, we don’t blink because we have … Continue reading →
The post Cancer Drugs Aren’t As Cost-Effective As They Used To Be appeared first on PeterUbel.com.
The authors looked at survey data from nearly 2000 next-of-kin surrogates of Health and Retirement Study participants with cancer who died between 2000 and 2012, including data from in-depth “exit” interviews conducted with the surrogates after the participant’s death. The HRS is a nationally representative, biennial, longitudinal panel study of US residents older than 50 years.
Patients receiving “all care possible” at EOL increased during the period (7% to 58%, P = .004). The authors concluded that "cancer care continues to be both highly intensive and geographically variable, likely driven in large part by local practice patterns instead of patients’ preferences."
by Craig Klugman, Ph.D.
This week a revision to the Florida advance directive law takes effect. The notable things in this new law are that it allows for one to appoint a health care surrogate for a minor, to have a surrogate’s authority be effective immediately, and it necessitates appointing a primary physician fro make end-of-life determinations.
The bill was passed in this spring and signed into law on June 11, 2015. It was introduced by Senator John Wood, Republican of District 41. His district is in the middle of the state containing the city of Winter Haven.
I am not an attorney and am not providing legal advice.…